Literature DB >> 20219474

Crystal structure of the botulinum neurotoxin type G binding domain: insight into cell surface binding.

Pål Stenmark1, Min Dong, Jérôme Dupuy, Edwin R Chapman, Raymond C Stevens.   

Abstract

Botulinum neurotoxins (BoNTs) typically bind the neuronal cell surface via dual interactions with both protein receptors and gangliosides. We present here the 1.9-A X-ray structure of the BoNT serotype G (BoNT/G) receptor binding domain (residues 868-1297) and a detailed view of protein receptor and ganglioside binding regions. The ganglioside binding motif (SxWY) has a conserved structure compared to the corresponding regions in BoNT serotype A and BoNT serotype B (BoNT/B), but several features of interactions with the hydrophilic face of the ganglioside are absent at the opposite side of the motif in the BoNT/G ganglioside binding cleft. This may significantly reduce the affinity between BoNT/G and gangliosides. BoNT/G and BoNT/B share the protein receptor synaptotagmin (Syt) I/II. The Syt binding site has a conserved hydrophobic plateau located centrally in the proposed protein receptor binding interface (Tyr1189, Phe1202, Ala1204, Pro1205, and Phe1212). Interestingly, only 5 of 14 residues that are important for binding between Syt-II and BoNT/B are conserved in BoNT/G, suggesting that the means by which BoNT/G and BoNT/B bind Syt diverges more than previously appreciated. Indeed, substitution of Syt-II Phe47 and Phe55 with alanine residues had little effect on the binding of BoNT/G, but strongly reduced the binding of BoNT/B. Furthermore, an extended solvent-exposed hydrophobic loop, located between the Syt binding site and the ganglioside binding cleft, may serve as a third membrane association and binding element to contribute to high-affinity binding to the neuronal membrane. While BoNT/G and BoNT/B are homologous to each other and both utilize Syt-I/Syt-II as their protein receptor, the precise means by which these two toxin serotypes bind to Syt appears surprisingly divergent. Copyright (c) 2010. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20219474      PMCID: PMC2928138          DOI: 10.1016/j.jmb.2010.02.041

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  36 in total

Review 1.  Expanding use of botulinum toxin.

Authors:  Roongroj Bhidayasiri; Daniel D Truong
Journal:  J Neurol Sci       Date:  2005-08-15       Impact factor: 3.181

2.  SV2 is the protein receptor for botulinum neurotoxin A.

Authors:  Min Dong; Felix Yeh; William H Tepp; Camin Dean; Eric A Johnson; Roger Janz; Edwin R Chapman
Journal:  Science       Date:  2006-03-16       Impact factor: 47.728

3.  Domain organization in Clostridium botulinum neurotoxin type E is unique: its implication in faster translocation.

Authors:  Desigan Kumaran; Subramaniam Eswaramoorthy; William Furey; Jorge Navaza; Martin Sax; Subramanyam Swaminathan
Journal:  J Mol Biol       Date:  2008-12-24       Impact factor: 5.469

Review 4.  The strange case of the botulinum neurotoxin: using chemistry and biology to modulate the most deadly poison.

Authors:  Bert Willis; Lisa M Eubanks; Tobin J Dickerson; Kim D Janda
Journal:  Angew Chem Int Ed Engl       Date:  2008       Impact factor: 15.336

5.  Crystal structure of botulinum neurotoxin type A and implications for toxicity.

Authors:  D B Lacy; W Tepp; A C Cohen; B R DasGupta; R C Stevens
Journal:  Nat Struct Biol       Date:  1998-10

6.  Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor concept.

Authors:  Andreas Rummel; Timo Eichner; Tanja Weil; Tino Karnath; Aleksandrs Gutcaits; Stefan Mahrhold; Konrad Sandhoff; Richard L Proia; K Ravi Acharya; Hans Bigalke; Thomas Binz
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-21       Impact factor: 11.205

7.  Structural basis of cell surface receptor recognition by botulinum neurotoxin B.

Authors:  Qing Chai; Joseph W Arndt; Min Dong; William H Tepp; Eric A Johnson; Edwin R Chapman; Raymond C Stevens
Journal:  Nature       Date:  2006-12-13       Impact factor: 49.962

8.  Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons.

Authors:  Min Dong; Huisheng Liu; William H Tepp; Eric A Johnson; Roger Janz; Edwin R Chapman
Journal:  Mol Biol Cell       Date:  2008-09-24       Impact factor: 4.138

9.  Subunit vaccine against the seven serotypes of botulism.

Authors:  Michael R Baldwin; William H Tepp; Amanda Przedpelski; Christina L Pier; Marite Bradshaw; Eric A Johnson; Joseph T Barbieri
Journal:  Infect Immun       Date:  2007-12-10       Impact factor: 3.441

10.  Mechanism of botulinum neurotoxin B and G entry into hippocampal neurons.

Authors:  Min Dong; William H Tepp; Huisheng Liu; Eric A Johnson; Edwin R Chapman
Journal:  J Cell Biol       Date:  2007-12-24       Impact factor: 10.539

View more
  12 in total

1.  Structural analysis of botulinum neurotoxin type G receptor binding .

Authors:  John Schmitt; Andrew Karalewitz; Desirée A Benefield; Darren J Mushrush; Rory N Pruitt; Benjamin W Spiller; Joseph T Barbieri; D Borden Lacy
Journal:  Biochemistry       Date:  2010-06-29       Impact factor: 3.162

2.  Botulinum neurotoxin D-C uses synaptotagmin I and II as receptors, and human synaptotagmin II is not an effective receptor for type B, D-C and G toxins.

Authors:  Lisheng Peng; Ronnie P-A Berntsson; William H Tepp; Rose M Pitkin; Eric A Johnson; Pål Stenmark; Min Dong
Journal:  J Cell Sci       Date:  2012-03-27       Impact factor: 5.285

Review 3.  Diverse binding modes, same goal: The receptor recognition mechanism of botulinum neurotoxin.

Authors:  Kwok-Ho Lam; Guorui Yao; Rongsheng Jin
Journal:  Prog Biophys Mol Biol       Date:  2015-02-19       Impact factor: 3.667

4.  Structural analysis of the receptor binding domain of botulinum neurotoxin serotype D.

Authors:  Yanfeng Zhang; Garry W Buchko; Ling Qin; Howard Robinson; Susan M Varnum
Journal:  Biochem Biophys Res Commun       Date:  2010-09-19       Impact factor: 3.575

5.  Molecular landscape of BoNT/B bound to a membrane-inserted synaptotagmin/ganglioside complex.

Authors:  Jorge Ramirez-Franco; Fodil Azzaz; Marion Sangiardi; Géraldine Ferracci; Fahamoe Youssouf; Michel Robert Popoff; Michael Seagar; Christian Lévêque; Jacques Fantini; Oussama El Far
Journal:  Cell Mol Life Sci       Date:  2022-08-25       Impact factor: 9.207

6.  Crystal structures of botulinum neurotoxin DC in complex with its protein receptors synaptotagmin I and II.

Authors:  Ronnie Per-Arne Berntsson; Lisheng Peng; Linda Marie Svensson; Min Dong; Pål Stenmark
Journal:  Structure       Date:  2013-08-08       Impact factor: 5.006

7.  Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors.

Authors:  Lisheng Peng; William H Tepp; Eric A Johnson; Min Dong
Journal:  PLoS Pathog       Date:  2011-03-31       Impact factor: 6.823

8.  A historical and proteomic analysis of botulinum neurotoxin type/G.

Authors:  Rebecca R Terilli; Hercules Moura; Adrian R Woolfitt; Jon Rees; David M Schieltz; John R Barr
Journal:  BMC Microbiol       Date:  2011-10-18       Impact factor: 3.605

9.  Structure of dual receptor binding to botulinum neurotoxin B.

Authors:  Ronnie P-A Berntsson; Lisheng Peng; Min Dong; Pål Stenmark
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

10.  A lipid-binding loop of botulinum neurotoxin serotypes B, DC and G is an essential feature to confer their exquisite potency.

Authors:  Daniel Stern; Jasmin Weisemann; Alexander Le Blanc; Laura von Berg; Stefan Mahrhold; Janett Piesker; Michael Laue; Peter B Luppa; Martin Bernhard Dorner; Brigitte Gertrud Dorner; Andreas Rummel
Journal:  PLoS Pathog       Date:  2018-05-02       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.